Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ...

Regeneron and Teva have announced positive top-line phase 3 results from their fasinumab, as the companies chase Pfizer and Lilly in the race to market a new class of non-opioid painkillers.

Complete Molson Coors Beverage Co. Cl B stock information by Barron's. View real-time TAP stock price and news, along with industry-best analysis.

2025 UFC event schedule: Robert Whittaker vs. Reinier de Ridder, Dricus du Plessis vs. Khamzat Chimaev on tap Check out a complete list of UFC pay-per-view and Fight Night events scheduled for 2025 ...